{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:10:25Z","timestamp":1774869025643,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.atherosclerosis.2014.10.101","type":"journal-article","created":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T16:17:34Z","timestamp":1414858654000},"page":"725-733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Ribose-cysteine increases glutathione-based antioxidant status and reduces LDL in human lipoprotein(a) mice"],"prefix":"10.1016","volume":"237","author":[{"given":"Tanjina","family":"Kader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn M.","family":"Porteous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Gieseg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally P.A.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90157-9","article-title":"A\u00a0population at risk. Prevalence of high cholesterol levels in hypertensive patents in the framingham study","volume":"80","author":"Castelli","year":"1986","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib3","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib4","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","article-title":"Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib5","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.108.836940","article-title":"Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race\/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the dallas heart study","volume":"119","author":"Tsimikas","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib6","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1089\/ars.2010.3586","article-title":"Glutathione peroxidase-1 in health and disease: from molecular mechanism to therapeutic opportunities","volume":"15","author":"Lubos","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0009-2797(81)90098-3","article-title":"Mechanistic aspects of enhanced lipid peroxidation following glutathione depletion in\u00a0vivo","volume":"34","author":"Younes","year":"1981","journal-title":"Chem. Biol. Interact."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2014.10.101_bib8","doi-asserted-by":"crossref","first-page":"e72063","DOI":"10.1371\/journal.pone.0072063","article-title":"Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib9","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa030535","article-title":"Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease","volume":"349","author":"Blankenberg","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2014.10.101_bib10","doi-asserted-by":"crossref","first-page":"e38901","DOI":"10.1371\/journal.pone.0038901","article-title":"Low serum glutathione peroxidase activity is associated with increased cardiovascular mortality in individuals with low HDLc's","volume":"7","author":"Buijsse","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib11","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","article-title":"Glutathione synthesis","volume":"1830","author":"Lu","year":"2013","journal-title":"Biochimica Biophysica Acta"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev.pa.25.040185.003435","article-title":"The regulation of hepatic glutathione","volume":"25","author":"Kaplowitz","year":"1985","journal-title":"Ann. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/0003-9861(57)90218-7","article-title":"Quantitative nutritional studies with water-soluble, chemically defined diets. III. Individual amino acids as sources of \u201cnon-essential\u201d nitrogen","volume":"72","author":"Birnbaum","year":"1957","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1183\/09031936.04.00016804","article-title":"Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease","volume":"23","author":"Dekhuijzen","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib15","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1007\/s00125-012-2685-z","article-title":"N-acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial","volume":"55","author":"Treweeke","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(95)91385-8","article-title":"Paracetamol (acetaminophen) poisoning","volume":"346","author":"Vale","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib17","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1021\/jm00393a034","article-title":"Prodrugs of L-cysteine as protective agents against acetaminophen-induced hepatotoxicity. 2-(polyhydroxyalkyl)-and 2-(polyacetoxyalkyl)thiazolidine-4(R)-carboxylic acids","author":"Roberts","year":"1987","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib18","first-page":"213","article-title":"Mechanisms of chemoprotection by RibCys, a thiazolidine prodrug of L-cysteine","volume":"1","author":"Roberts","year":"1991","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0378-4274(91)90078-K","article-title":"Time course for the elevation of glutathione in numerous organs of L1210-bearing CDF1 mice given the L-cysteine prodrug, RibCys","volume":"59","author":"Roberts","year":"1991","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib20","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1172\/JCI116927","article-title":"Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)","volume":"92","author":"Linton","year":"1993","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib21","doi-asserted-by":"crossref","first-page":"24369","DOI":"10.1016\/S0021-9258(18)35775-2","article-title":"Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a)","volume":"267","author":"Chiesa","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0165-022X(86)90102-8","article-title":"Methodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systems","volume":"13","author":"Cotgreave","year":"1986","journal-title":"J.\u00a0Biochem. Biophys. Methods"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib23","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1016\/S0021-9258(19)44679-6","article-title":"The generation of superoxide radicals during the auto-oxidation of hemoglobin","volume":"247","author":"McCord","year":"1972","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib24","series-title":"Methods in pharmacology and toxicology: methods in biological oxidative stress","article-title":"Fluorometric and colourimetric assessment of thiobarbituric acid-reactive lipid aldehydes in biological matrices","author":"Williamson","year":"2003"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib25","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2337\/diabetes.51.4.1233","article-title":"Hepatic expression of microsomal triglyceride transfer protein and in\u00a0vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice","volume":"51","author":"Bartels","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib26","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI117915","article-title":"Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet","volume":"95","author":"Purcell-Huynh","year":"1995","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib28","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/clinchem\/41.2.246","article-title":"Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a)","volume":"41","author":"Marcovina","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0021-9258(19)40266-4","article-title":"Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100","volume":"265","author":"Pease","year":"1990","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1600-0773.1992.tb00472.x","article-title":"Protection against acetaminophen hepatotoxicity by ribose-cysteine (Rib-Cys)","volume":"70","author":"Roberts","year":"1992","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1177\/019262330002800510","article-title":"Ribose cysteine protects against acetaminophen-induced hepatic and renal toxicity","volume":"28","author":"Lucas","year":"2000","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jn\/134.1.149","article-title":"Five cysteine-containing compounds have antioxidative activity in Balb\/cA Mice","volume":"134","author":"Hsu","year":"2004","journal-title":"J.\u00a0Nutr."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.etap.2014.01.024","article-title":"Effect of N-acetylcysteine administration on the expression and activities of antioxidant enzymes and the malondialdehyde level in the blood of lead-exposed workers","volume":"37","author":"Kasperczyk","year":"2014","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0009-8981(86)90247-0","article-title":"The relationship between plasma triglycerides, cholesterol, total lipids and lipid peroxidation products during human atherosclerosis","volume":"155","author":"Ledwozyw","year":"1986","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0008-6363(97)00185-5","article-title":"Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls","volume":"36","author":"Kostner","year":"1997","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/10715769309056498","article-title":"Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test","volume":"19","author":"Chirico","year":"1993","journal-title":"Free Rad. Res. Comms"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7827(97)00001-5","article-title":"The isoprostanes: unique bioactive products of lipid peroxidation","volume":"36","author":"Morrow","year":"1997","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib38","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1172\/JCI200421637","article-title":"Hold the antioxidants and improve plasma lipids?","volume":"113","author":"Krauss","year":"2004","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(84)90135-1","article-title":"Why does plasma low density lipoprotein concentration in adults increase with age?","volume":"323","author":"Miller","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib40","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/ptr.4646","article-title":"Quercetin up-regulates LDL receptor expression in HepG2 cells","volume":"26","author":"Moon","year":"2012","journal-title":"Phytother. Res."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0007114507793881","article-title":"Effects of cysteine containing compounds on biosynthesis of triacylglycerol and cholesterol and anti-oxidative protection in liver from mice consuming a high-fat diet","volume":"99","author":"Lin","year":"2008","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0140-6736(91)92161-T","article-title":"Lipoprotein(a) reduction by N-Acetylcysteine","volume":"337","author":"Gavish","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/953461","article-title":"Acute phase reactants as novel predictors of cardiovascular disease","volume":"2012","author":"Ahmed","year":"2012","journal-title":"ISRN Inflamm."},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib44","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI114602","article-title":"Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice","author":"Hofmann","year":"1990","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib45","first-page":"1","article-title":"Lipoprotein(a) metabolism: potential sites for therapeutic targets","author":"Hoover-Plow","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(02)09328-5","article-title":"MRC\/BHF heart protection study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2014.10.101_bib47","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/01.ATV.9.4.462","article-title":"Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer","volume":"9","author":"Franceschini","year":"1989","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014015561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014015561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T02:17:50Z","timestamp":1650507470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014015561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0021915014015561"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.10.101","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ribose-cysteine increases glutathione-based antioxidant status and reduces LDL in human lipoprotein(a) mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.10.101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}